Statins and ARBs on Rheumatoid Activity

ConditionRheumatoid Arthritis

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age18-65

SponsorSherief Abd-Elsalam

About this trial

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Rheumatoid arthritis.

Disqualifiers

Pregnant or lactating

Hepatic or renal impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

Angiotensin receptor blockers
Drug
Candesartan
Statins
Drug
Atorvastatin

Treatment groups

45 Participants

are divided into 3 treatment groups

Group A: Control groupNo intervention 0 interventions

Group B: Angiotensin receptor blockersActive comparator 1 intervention

Group C: StatinsActive comparator 1 intervention

Trial outcomes

Primary outcomes

Change in disease activity score

DAS28-ESR

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov

Apply now